These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1029233)

  • 21. [Kidney involvement in liver diseases. Pathophysiology and clinical course].
    Schmidt P
    Klin Wochenschr; 1983 Oct; 61(20):1039-47. PubMed ID: 6645304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
    Arbeiter G; Meyer-Burg J
    Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The liver in the physiopathology of iron. I. Plasmatic circulation of iron (hepatic cirrhosis and necrosis)].
    Robalo Cordeiro AJ; Trincao RC; Breda Coimbra HL; Mesquita A; Proença MS; Severo FR; Almeida JC
    Rev Int Hepatol; 1966; 16(6):1165-98. PubMed ID: 5960037
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biochemistry of hepatic encephalopathy].
    Knaś M; Zwierz K
    Przegl Epidemiol; 2006; 60 Suppl 1():62. PubMed ID: 16909779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ; Losowsky MS
    Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurologic complications of liver diseases].
    Wewalka F
    Wien Z Nervenheilkd Grenzgeb; 1971; 29(1):95-106. PubMed ID: 4256005
    [No Abstract]   [Full Text] [Related]  

  • 29. [The so called hepatic encephalopathy. Pathophysiology and diagnosis].
    Spatz R; Kollmannsberger A
    Munch Med Wochenschr; 1971 Sep; 113(39):1250-4. PubMed ID: 5171156
    [No Abstract]   [Full Text] [Related]  

  • 30. [Secondary aldosteronism in patients with liver cirrhosis and excretion of aldosterone in them following vascular anastomosis].
    Sprintsson RG
    Vestn Khir Im I I Grek; 1966 Oct; 97(10):15-8. PubMed ID: 6001770
    [No Abstract]   [Full Text] [Related]  

  • 31. [The hepatorenal syndrome: etiopathogenetic, clinical and therapeutic considerations].
    Mancinella A
    Clin Ter; 1976 Dec; 79(6):583-90. PubMed ID: 795602
    [No Abstract]   [Full Text] [Related]  

  • 32. The renin-angiotensin-aldosterone system in sodium depletion.
    Blair-West JR; Coghlan JP; Denton DA; Scoggins BA; Wintour M; Wright RD
    Med J Aust; 1967 Aug; 2(7):290-3. PubMed ID: 4293019
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathogenesis of ascites in cirrhosis of liver. II.
    Liebowitz HR
    N Y State J Med; 1969 Jul; 69(14):2012-24. PubMed ID: 4894218
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of aldosterone in edema formation.
    Wolff HP; Blaise BH; Düsterdieck G; Jahnecke J; Kobayashi T; Krück F; Lommer D; Schieffer H
    Ann N Y Acad Sci; 1966 Nov; 139(2):285-94. PubMed ID: 4291331
    [No Abstract]   [Full Text] [Related]  

  • 35. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic mucormycosis in a child with fulminant hepatic failure.
    Erdem G; Cağlar M; Ceyhan M; Akçören Z; Kanra G
    Turk J Pediatr; 1996; 38(4):511-4. PubMed ID: 8993182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pig liver perfusion in the treatment of acute hepatic failure.
    Ranek L; Hansen RI; Hilden M; Ramsöe K; Schmidt A; Winkler K; Tygstrup N
    Scand J Gastroenterol Suppl; 1971; 9():161-9. PubMed ID: 5284139
    [No Abstract]   [Full Text] [Related]  

  • 38. Angiotensinase activity using human crude angiotensin.
    Asano S; Ozawa Y; Arai J; Saruta T; Higashi F
    Jpn Circ J; 1968 Feb; 32(2):133-6. PubMed ID: 4297902
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of chronic hepatitis and liver cirrhosis and their complications. 2. Treatment of portal hypertension and hepatic coma].
    Schimmelpfennig W; Wagner K; Schneider G; Zimmermann HB
    Z Arztl Fortbild (Jena); 1974 Jun; 68(12):587-91 concl. PubMed ID: 4428790
    [No Abstract]   [Full Text] [Related]  

  • 40. [The electroencephalogram in liver diseases].
    Scollo-Lavizzari G
    Dtsch Med Wochenschr; 1969 May; 94(19):1020-1. PubMed ID: 5779802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.